| Site Map | Devices | InVitro Diagnostics | Health and WellBeing | Combination Products |
| Our Team | Our Services | Our Seminars | Our News | Contact Us |
The headline and some of the content give a rather different feel to our press release . Nevermind, all publicity is good publicity as they say!
A COMPANY in Stevenage has forged a major link with a European partner that will further revolutionise the safe
administration of drugs.
MeddiQuest, who have their headquarters at the Business and Technology Centre in Bessemer Drive, have teamed up with Schultz Interactive Information of Denmark to develop a human drug module to administer correct doses of drugs.
Schultz is a private company that lets as the government printing office in Denmark and the companies hope to develop the module further to cover medical devices.
"Safety in the healthcare industry will increasingly centre around matching new active pharmaceuticals and biological compounds with devices to deliver an accurate targeted dose and monitor its benefits," said MeddiQuest managing director Neil Armstrong.
"The partnering arrangement with Schultz demonstrates our joint belief that the traditional boundaries between drugs and devices are gradually disappearing and that a unified approach to regulating healthcare products is essential."
Mr Armstrong firmly believes this view was given added weight recently by the announcement that the UK Medical Devices Agency and Medicines Control Agency will merge next year.
MeddiQuest will assist Schultz in reviewing and determining the applicability of regulation and guidance from government agencies to ensure that the device regulatory requirements are integrated into their established human drug module.
It is hoped that in the future scientists will have access to the full range of EU and US regulations, indexed, bookmarked and customised on their desktops.
"We are very excited about this project and where it is taking the company, which was only set up last year," added Mr Armstrong.
"Hopefully the human module will be fully operational within two years and will be updated monthly because drug legislation both here and in the US changes very quickly with new laws coming in all the time.
"But I believe our partnership with Shultz will provide a valuable resource to drug and device development companies and ultimately ensure that new safe and effective treatments are available earlier."
MeddiQuest Limited / Business and Technology Centre / Bessemer Drive / Stevenage / Herts. / SG1 2DX / England
T: +44 1763 222505(O) F: +44 1438 310001 e:
meddiquest@meddiquest.com web: www.meddiquest.comDirectors: NR Armstrong, AS Spencer; Co. Reg. #4226188 Registered Office: 116 Layston Park / Royston / Herts. / SG8 9DY
| Site Map | Devices | InVitro Diagnostics | Health and WellBeing | Combination Products |
| Our Team | Our Services | Our Seminars | Our News | Contact Us |
email us at
info@meddiquest.com